Transaction in Own Shares

Fidelity Emerging Markets Limited repurchased and cancelled 90,392 ordinary shares on 23 December 2025 at an average price of 1,039.060 GBp (low 1,036.000 GBp; high 1,040.000 GBp). After the buyback the company reports issued share capital of 53,628,701, 9,025,940 shares held in treasury and total voting rights of 44,602,762; treasury shares carry no voting rights. The transaction modestly reduces shares outstanding and signals capital return intent but is small relative to issued capital and is unlikely to materially move the stock on its own.

Analysis

Market structure: The buyback (90,392 shares at an average 1,039.06p) is economically tiny (~0.17% of issued capital) but symbolically meaningful because the trust already holds 9,025,940 shares in treasury (~16.8% of issued capital) and a reduced free float (voting rights 44.6m). That small cancellation tightens tradable supply and increases per‑share NAV sensitivity, so price moves can be amplified versus underlying EM assets; expect modest narrowing of the discount/premium over the next 1–3 months if management continues buybacks.

Risk assessment: Tail risks are dominated by EM macro shocks (sharp EM FX devaluation, China slowdown) that can wipe out NAV faster than discount contraction; regulatory/UK corporate action risk is low but policy changes on buybacks or tax treatment could occur within 6–12 months. Hidden dependency: efficacy depends on source of funds (liquidating winners vs cash) — if funded by selling high‑conviction holdings, future performance may suffer. Catalysts to watch: further tender programs, quarterly NAV reports, and 30–60 day EM inflow spikes.

Trade implications: Direct play is to capture discount compression with low EM beta exposure — pair long the trust vs short an EM ETF (e.g., long Fidelity Emerging Markets Ltd (FEM on LSE) vs short EEM or VWO) sized to neutralize NAV beta; target capture 4–10% discount tightening within 1–3 months. Use option structures (buy 3‑month FEM call spread or sell covered calls if long) to monetize limited upside and generate yield while capping downside.

Contrarian angles: Consensus treats this as benign buyback support; the overlooked risk is illiquidity — with large treasury holdings and small free float, a single large sell order or NAV shock can widen the discount violently. Historical analogues (closed‑end EM trusts in 2018–19) show buybacks can fail to protect price in sharp EM drawdowns, so require strict stops (6–8%) and monitoring of NAV funding sources over next 90 days.

Key Decisions for Investors

• Establish a 2–3% portfolio position long Fidelity Emerging Markets Limited (FEM on LSE) to capture potential 4–10% discount narrowing over 1–3 months; set stop‑loss at 6% below entry and target exit when discount narrows by ≥4% or within 90 days.
• Implement a pair trade: long FEM (size A) and short EEM (iShares MSCI Emerging Markets ETF) sized to neutralize underlying EM beta — aim to isolate discount/manager signal; hold 1–3 months, trim if NAV underperforms EM by >3% in 30 days.
• If long FEM, sell 1–2 month covered calls (strike roughly 4–6% above current price) to earn yield while capping upside; alternatively buy 3‑month FEM call spreads to limit premium spend if expecting further buybacks.
• Avoid increasing outright EM beta exposure based solely on this buyback; limit incremental EM equity allocation to +1–2% until next NAV update and any announced repeat buyback program within 60 days verifies management intent.